-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Asensus Surgical (NYSEAMERICAN:ASXC) Receives New Coverage From Analysts at Cantor Fitzgerald
Asensus Surgical (NYSEAMERICAN:ASXC) Receives New Coverage From Analysts at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) in a report issued on Thursday morning, The Fly reports. The brokerage issued an overweight rating and a $1.50 target price on the stock.
Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $4.00 to $3.00 in a research note on Wednesday, August 10th.
Get Asensus Surgical alerts:Asensus Surgical Stock Performance
ASXC stock opened at $0.54 on Thursday. Asensus Surgical has a one year low of $0.35 and a one year high of $2.31.
Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) last issued its earnings results on Monday, August 8th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.01. The firm had revenue of $0.99 million during the quarter, compared to analysts' expectations of $1.25 million.Institutional Trading of Asensus Surgical
Hedge funds have recently modified their holdings of the business. Millennium Management LLC boosted its stake in Asensus Surgical by 3,552.4% in the 2nd quarter. Millennium Management LLC now owns 5,040,838 shares of the company's stock worth $2,007,000 after purchasing an additional 4,902,823 shares in the last quarter. Walker Asset Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $138,000. Advisor Group Holdings Inc. lifted its stake in Asensus Surgical by 12.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 279,923 shares of the company's stock valued at $2,090,000 after acquiring an additional 30,676 shares during the period. AQR Capital Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $106,000. Finally, GSA Capital Partners LLP bought a new position in Asensus Surgical during the 1st quarter valued at about $138,000.
About Asensus Surgical
(Get Rating)
Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.
Featured Articles
- Get a free copy of the StockNews.com research report on Asensus Surgical (ASXC)
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- Are These Green Energy Companies Right For Your Portfolio?
- When Will the Hangover Finally Be Over for Seagate Technology?
- Does Enphase Energy Have the Juice to Keep Powering Higher?
- The One Hydrogen Fuel Cell Stock To Rule Them All
Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
Cantor Fitzgerald started coverage on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) in a report issued on Thursday morning, The Fly reports. The brokerage issued an overweight rating and a $1.50 target price on the stock.
據The Fly報道，康託·菲茨傑拉德在週四上午發佈的一份報告中開始報道Ascount Surgical(NYSEAMERICAN：ASXC-GET Rating)的股票。該經紀公司對該股發佈了增持評級和1.50美元的目標價。
Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $4.00 to $3.00 in a research note on Wednesday, August 10th.
另外，在8月10日星期三的一份研究報告中，HC Wainwright將Ascount Surgical的目標股價從4.00美元下調至3.00美元。
Asensus Surgical Stock Performance
Ascount外科類股表現
ASXC stock opened at $0.54 on Thursday. Asensus Surgical has a one year low of $0.35 and a one year high of $2.31.
週四，ASXC股價開盤報0.54美元。Ascount Surgical的一年低點為0.35美元，一年高位為2.31美元。
Institutional Trading of Asensus Surgical
資產評估外科的機構交易
Hedge funds have recently modified their holdings of the business. Millennium Management LLC boosted its stake in Asensus Surgical by 3,552.4% in the 2nd quarter. Millennium Management LLC now owns 5,040,838 shares of the company's stock worth $2,007,000 after purchasing an additional 4,902,823 shares in the last quarter. Walker Asset Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $138,000. Advisor Group Holdings Inc. lifted its stake in Asensus Surgical by 12.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 279,923 shares of the company's stock valued at $2,090,000 after acquiring an additional 30,676 shares during the period. AQR Capital Management LLC bought a new position in Asensus Surgical during the 2nd quarter valued at about $106,000. Finally, GSA Capital Partners LLP bought a new position in Asensus Surgical during the 1st quarter valued at about $138,000.
對衝基金最近調整了對該業務的持股。千禧管理有限責任公司在第二季度將其在Ascount Surgical的持股增加了3552.4%。Millennium Management LLC在上個季度又購買了4,902,823股後，現在擁有5,040,838股該公司股票，價值2,007,000美元。Walker Asset Management LLC在第二季度購買了Ascount Surgical的一個新頭寸，價值約13.8萬美元。Advisor Group Holdings Inc.在第一季度增持了Ascount Surgical 12.3%的股份。Advisor Group Holdings Inc.在此期間增持了30,676股，目前持有279,923股該公司股票，價值2,090,000美元。AQR Capital Management LLC在第二季度購買了Ascount Surgical的一個新頭寸，價值約10.6萬美元。最後，GSA Capital Partners LLP在第一季度購買了Ascount Surgical的一個新頭寸，價值約13.8萬美元。
About Asensus Surgical
關於Ascount Surgical
(Get Rating)
(獲取評級)
Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.
Ascount Surgical，Inc.是一家醫療設備公司，從事醫療設備機器人的研究、開發和銷售，以增強美國、歐洲和亞洲的微創手術(MIS)。它將外科醫生和患者之間的接口數字化，通過為外科醫生釋放臨牀智能來開創性能指導手術的新時代，以實現始終如一的卓越結果和新的手術標準。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Asensus Surgical (ASXC)
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- Are These Green Energy Companies Right For Your Portfolio?
- When Will the Hangover Finally Be Over for Seagate Technology?
- Does Enphase Energy Have the Juice to Keep Powering Higher?
- The One Hydrogen Fuel Cell Stock To Rule Them All
- 免費獲取StockNews.com關於Ascount Surgical(ASXC)的研究報告
- 石油和天然氣股票：投資可再生能源的安全途徑
- 這些綠色能源公司適合你的投資組合嗎？
- 希捷科技的宿醉何時才能結束？
- 安相能源有足夠的動力繼續提高動力嗎？
- 獨一無二的氫燃料電池庫存
Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《評估外科日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Ascount Surgical及相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧